These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23535561)

  • 1. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.
    Narumi T; Arai H; Yoshimura K; Harada S; Hirota Y; Ohashi N; Hashimoto C; Nomura W; Matsushita S; Tamamura H
    Bioorg Med Chem; 2013 May; 21(9):2518-26. PubMed ID: 23535561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecular CD4 mimics as HIV entry inhibitors.
    Narumi T; Arai H; Yoshimura K; Harada S; Nomura W; Matsushita S; Tamamura H
    Bioorg Med Chem; 2011 Nov; 19(22):6735-42. PubMed ID: 22014753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120.
    Neffe AT; Meyer B
    Angew Chem Int Ed Engl; 2004 May; 43(22):2937-40. PubMed ID: 15170309
    [No Abstract]   [Full Text] [Related]  

  • 4. CD4 mimics targeting the HIV entry mechanism and their hybrid molecules with a CXCR4 antagonist.
    Narumi T; Ochiai C; Yoshimura K; Harada S; Tanaka T; Nomura W; Arai H; Ozaki T; Ohashi N; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5853-8. PubMed ID: 20728351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors.
    Ohashi N; Harada S; Mizuguchi T; Irahara Y; Yamada Y; Kotani M; Nomura W; Matsushita S; Yoshimura K; Tamamura H
    ChemMedChem; 2016 Apr; 11(8):940-6. PubMed ID: 26891461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4 mimics targeting the mechanism of HIV entry.
    Yamada Y; Ochiai C; Yoshimura K; Tanaka T; Ohashi N; Narumi T; Nomura W; Harada S; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):354-8. PubMed ID: 19926478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational studies identifying entry inhibitor scaffolds targeting the Phe43 cavity of HIV-1 gp120.
    Tintori C; Selvaraj M; Badia R; Clotet B; Esté JA; Botta M
    ChemMedChem; 2013 Mar; 8(3):475-83. PubMed ID: 23404750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic bivalent CD4-mimetic miniproteins show enhanced anti-HIV activity over the monovalent miniprotein.
    Li H; Song H; Heredia A; Le N; Redfield R; Lewis GK; Wang LX
    Bioconjug Chem; 2004; 15(4):783-9. PubMed ID: 15264865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular docking guided structure based design of symmetrical N,N'-disubstituted urea/thiourea as HIV-1 gp120-CD4 binding inhibitors.
    Sivan SK; Vangala R; Manga V
    Bioorg Med Chem; 2013 Aug; 21(15):4591-9. PubMed ID: 23777826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.
    Zhao Q; Ma L; Jiang S; Lu H; Liu S; He Y; Strick N; Neamati N; Debnath AK
    Virology; 2005 Sep; 339(2):213-25. PubMed ID: 15996703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction.
    Williams DH; Adam F; Fenwick DR; Fok-Seang J; Gardner I; Hay D; Jaiessh R; Middleton DS; Mowbray CE; Parkinson T; Perros M; Pickford C; Platts M; Randall A; Siddle D; Stephenson PT; Tran TD; Vuong H
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5246-9. PubMed ID: 19620004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding.
    Uttekar MM; Das T; Pawar RS; Bhandari B; Menon V; Nutan ; Gupta SK; Bhat SV
    Eur J Med Chem; 2012 Oct; 56():368-74. PubMed ID: 22858223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors.
    Tsuji K; Kobayakawa T; Konno K; Masuda A; Takahashi K; Ohashi N; Yoshimura K; Kuwata T; Matsushita S; Harada S; Tamamura H
    Bioorg Med Chem; 2022 Feb; 56():116616. PubMed ID: 35063895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and optimisation of potent gp120-CD4 inhibitors.
    Tran TD; Adam FM; Calo F; Fenwick DR; Fok-Seang J; Gardner I; Hay DA; Perros M; Rawal J; Middleton DS; Parkinson T; Pickford C; Platts M; Randall A; Stephenson PT; Vuong H; Williams DH
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5250-5. PubMed ID: 19632839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dynamic target-based pharmacophoric model mapping the CD4 binding site on HIV-1 gp120 to identify new inhibitors of gp120-CD4 protein-protein interactions.
    Caporuscio F; Tafi A; González E; Manetti F; Esté JA; Botta M
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6087-91. PubMed ID: 19783140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.
    Curreli F; Kwon YD; Belov DS; Ramesh RR; Kurkin AV; Altieri A; Kwong PD; Debnath AK
    J Med Chem; 2017 Apr; 60(7):3124-3153. PubMed ID: 28266845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.
    Curreli F; Haque K; Xie L; Qiu Q; Xu J; Yong W; Tong X; Debnath AK
    Bioorg Med Chem; 2015 Dec; 23(24):7618-28. PubMed ID: 26602829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
    Hamza A; Zhan CG
    J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth.
    Huang CC; Stricher F; Martin L; Decker JM; Majeed S; Barthe P; Hendrickson WA; Robinson J; Roumestand C; Sodroski J; Wyatt R; Shaw GM; Vita C; Kwong PD
    Structure; 2005 May; 13(5):755-68. PubMed ID: 15893666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic mimetics of the CD4 binding site of HIV-1 gp120 for the design of immunogens.
    Franke R; Hirsch T; Overwin H; Eichler J
    Angew Chem Int Ed Engl; 2007; 46(8):1253-5. PubMed ID: 17211914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.